ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Neuropace Inc

Neuropace Inc (NPCE)

9.70
0.70
(7.78%)
Cerrado 23 Noviembre 3:00PM
9.697
-0.003
(-0.03%)
Fuera de horario: 6:59PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
9.70
Postura de Compra
9.52
Postura de Venta
10.07
Volume Operado de la Acción
67,028
8.9079 Rango del Día 9.70
5.45 Rango de 52 semanas 18.15
Capitalización de Mercado [m]
Precio Anterior
9.00
Precio de Apertura
9.06
Última hora de negociación
Volumen financiero
US$ 623,247
Precio Promedio Ponderado
9.2983
Volumen promedio (3 m)
72,877
Acciones en circulación
29,848,101
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-8.79
Beneficio por acción (BPA)
-1.1
turnover
65.42M
Beneficio neto
-32.96M

Acerca de Neuropace Inc

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically ... NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System. Mostrar más

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Neuropace Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NPCE. The last closing price for Neuropace was US$9. Over the last year, Neuropace shares have traded in a share price range of US$ 5.45 to US$ 18.15.

Neuropace currently has 29,848,101 shares in issue. The market capitalisation of Neuropace is US$268.63 million. Neuropace has a price to earnings ratio (PE ratio) of -8.79.

NPCE Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.171.783840503679.539.838.34545169.02867867CS
43.5958.75613747956.1110.42025.451190807.72773791CS
121.7421.85929648247.9610.42025.45728777.32887651CS
261.8323.25285895817.8710.42025.45875987.24703366CS
521.2314.52184179468.4718.155.45966219.9976442CS
156-2.28-19.031719532611.9818.151.22690617.62681838CS
260-13.55-58.279569892523.2527.381.227611111.14183662CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.41M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.36M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
95.06M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
107.91M

Su Consulta Reciente

Delayed Upgrade Clock